CellImmunologyPeer-reviewed journal article
Analysis of the Diverse Antigenic Landscape of the Malaria Invasion Protein RH5 Identifies a Potent Vaccine-Induced Human Public Antibody Clonotype
J. R. Barrett, D. Pipini, N. D. Wright, A. J. R. Cooper, G. Gorini, D. Quinkert, A. M. Lias, H. Davies, C. Rigby, M. Aleshnick, B. G. Williams, W. J. Bradshaw, N. G. Paterson, T. Martinson, P. Kirtley, L. Picard, C. D. Wiggins, F. R. Donnellan, L. D. W. King, L. T. Wang, J. F. Popplewell, S. E. Silk, J. d. R. Swain, K. Skinner, V. Kotraiah, , S. J. Draper
Abstract
The highly conserved and essential Plasmodium falciparum reticulocyte-binding protein homolog 5 (PfRH5) has emerged as the leading target for vaccines that seek to protect against the disease-causing blood-stage of malaria. However, the features of the human vaccine-induced antibody response that confer highly potent inhibition of malaria parasite invasion into red blood cells are not well defined. Here we characterize over 200 human IgG monoclonal antibodies induced by the most advanced PfRH5 vaccine. We define the antigenic landscape of this molecule, and establish epitope specificity, antibody association rate and intra-PfRH5 antibody interactions are key determinants of functional anti-parasitic potency. In addition, we identify a germline gene combination that results in an exceptionally potent class of antibody and demonstrate its prophylactic potential to protect against P. falciparum parasite challenge in vivo. This comprehensive dataset provides a framework to guide rational design of next-generation vaccines and prophylactic antibodies to protect against blood-stage malaria.
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- research focus: cell type annotation
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Synergistic non-neutralizing plasma antibodies to PfRH5 drive potent malaria parasite growth inhibition
Jeffrey Marchioni, Kirsty McHugh, … Jason J. Lavinder·bioRxiv·Dec 26, 2025
- The Dual Action of Human Antibodies Specific to Plasmodium falciparum PfRH5 and PfCyRPA: Blocking Invasion and Inactivating Extracellular Merozoites
G. E. Weiss, R. J. Ragotte, … P. R. Gilson·bioRxiv·Feb 7, 2023
- Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5
L. T. Wang, A. J. R. Cooper, … J. Tan·bioRxiv·Oct 4, 2023
- Preclinical Development of a Stabilized RH5 Virus-Like Particle Vaccine that Induces Improved Anti-Malarial Antibodies
L. D. W. King, D. Pulido, … S. J. Draper·bioRxiv·Jan 4, 2024
- Rational structure-guided design of a blood stage malaria vaccine immunogen presenting a single epitope from PfRH5
T. Harrison, N. Alam, … I. Campeotto·bioRxiv·Feb 29, 2024
- Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex
B. G. Williams, L. D. W. King, … S. J. Draper·Nature CommunicationsPeer-reviewed·Jun 7, 2024